Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351234 · ClinicalTrials.gov registry record
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
A clinical trial of Hypoglycemia and Diabetes Mellitus, Type I, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00351234 is a study of Hypoglycemia and Diabetes Mellitus, Type I that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 200 participants, below the 502-participant average among 40 other Hypoglycemia trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00351234, a study of Hypoglycemia and Diabetes Mellitus, Type I, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether type I diabetics with carnitine deficiency exhibit increased numbers of hypoglycemic (low blood sugars) events and if unrecognized hypoglycemia occurs during continuous 72-hour glucose monitoring. If they are determined to have unrecognized hypoglycemia, then oral carnitine supplementation will be given to those subjects and they will be reassessed for the number of hypoglycemic events in a 72-hour glucose monitoring.
Conditions Studied
Interventions
- DRUG Carnitine (drug)
Study Locations (1)
Missouri
- The Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00351234
The ClinicalTrials.gov registry entry for NCT00351234 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 502-participant average among 40 other Hypoglycemia trials with a reported enrollment target (60% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypoglycemia appearing as the primary indexed condition, and to 1 intervention - of which Carnitine (drug) is the first listed.
NCT00351234 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00351234 about?
NCT00351234 is a clinical study titled "Carnitine Levels and Carnitine Supplementation in Type I Diabetes". The purpose of this study is to determine whether type I diabetics with carnitine deficiency exhibit increased numbers of hypoglycemic (low blood sugars) events and if unrecognized hypoglycemia occurs during continuous 72-hour glucose monitoring. If they are determined to have unrecognized hypoglyce...
What is the current status of trial NCT00351234?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2004-10. Estimated completion is 2007-04.
What conditions does trial NCT00351234 study?
This clinical trial studies the following conditions: Hypoglycemia, Diabetes Mellitus, Type I.
What interventions are being tested in trial NCT00351234?
The interventions under investigation include: Carnitine (drug) (DRUG).
Who is sponsoring clinical trial NCT00351234?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00351234 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia
RECRUITING
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
RECRUITING · NA
-
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
RECRUITING · NA
-
Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.